Transcatheter Aortic Valve Replacement Tag

26 Sep Greater Treatment Options for AVS Patients with a Lower Surgical Risk of Major Complications

Last month, the U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, that protects the public health, approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis (Sapien 3, Sapien 3 Ultra, CoreValve...

Read More

20 Jun Study Says Most Patients Can Now Benefit from TAVR Procedure

According to the Columbia Surgery blog, Transcatheter Aortic Valve Replacement (TAVR), is considered the new “gold-standard” for treating people suffering from aortic valve disease. [caption id="attachment_1523" align="alignleft" width="300"] An estimated 300,000 Americans are diagnosed annually with severe aortic stenosis, a condition where the aortic valve doesn’t...

Read More